Sarcopenia is a geriatric syndrome with a significant impact on older patients' quality of life,
morbidity and mortality. Despite the new available criteria, its early diagnosis remains …

Decreased muscle mass and function, also known as sarcopenia, is common in patients
with cirrhosis and is associated with a poor prognosis. Although the pathogenesis of this …

Skeletal muscle and brown adipose tissue (BAT) are functionally linked, as exercise
increases browning via secretion of myokines. It is unknown whether BAT affects muscle …

Immune checkpoint inhibitors (ICIs) have been increasingly used in combination for cancer
treatment but are associated with myocarditis. Here, we report that tumor-bearing mice …

Cardiac cachexia (CC) is the clinical entity at the end of the chronic natural course of heart
failure (HF). Despite the efforts, even the most recent definition of cardiac cachexia has been …

Facioscapulohumeral muscular dystrophy (FSHD), a common hereditary myopathy, is
caused either by the contraction of the D4Z4 macrosatellite repeat at the distal end of …

Background Cancer‐associated cachexia (CAC) is a complex syndrome of progressive
muscle wasting and adipose loss with metabolic dysfunction, severely increasing the …

Sarcopenia is defined as low muscle function (walking speed or grip strength) in the
presence of low muscle mass. A simple screening test—the SARC-F—is available to identify …

Introduction and aim Myostatin and follistatin are the main hormones for regulating muscle
mass, and previous research suggests they are modulated by resistance training. We …

Simple Summary The primary characteristics of cancer cachexia are weakness, weight loss,
atrophy, fat reduction, and systemic inflammation. Cachexia is strongly associated with …